Reregistration Eligibility Decision (RED): Triclopyr. (Includes RED Facts:211 Triclopyr Fact Sheet)

摘要

This document presents the Agency's decision regarding the reregistration211u001eeligibility of the registered uses of triclopyr including the risk to infants and 211u001echildren for any potential dietary, drinking water, dermal or oral exposures, and 211u001ecumulative effects as stipulated under the FQPA. Section I is the introduction. 211u001eSection II describes triclopyr, its uses, data requirements and regulatory 211u001ehistory. Section III discusses the human health and environmental assessment 211u001ebased on the data available to the Agency. Section IV presents the reregistration 211u001edecision for triclopyr. Section V discusses the reregistration requirements for 211u001etriclopyr. Finally, Section VI is the Appendices which support this 211u001eReregistration Eligibility Decision.